ORI Updates

ORI found that Dr. Venkata J. Reddy intentionally and knowingly engaged in research misconduct by falsifying and/or fabricating data that was provided to his mentor to include in grant application.

Teresita Briones intentionally, knowingly, and recklessly engaged in research misconduct by falsifying and/or fabricating data that were included in five publications and three grant applications.

ORI found that Dr. Ryousuke Fujita engaged in research misconduct by falsifying and fabricating data that included in figures in the following two publications and one unpublished manuscript.

Join the U.S. Health and Human Services team as the Director for the Office of Research Integrity.  Applications are being accepted until May 15, 2015.

The NIH Office of Extramural Research and the HHS Office for Human Research Protections are offering a full day workshop entitled "Getting through Human Research Reviews without Pain"Sign up on Wednesday, May 6th.   The NIH Regional Seminar will be held May 6 to May 9 at the Renaissance Harborplace Hotel in Baltimore, MD.

ORI is seeking qualified applicants to fill positions in the Division of Education and Integrity to help develop and manage programs to promote research integrity. Application deadline is April 6, 2015.

ORI is seeking to fund projects that foster innovative approaches to empirical research on societal, organizational, group, and individual factors that affect, both positively and negatively, integrity in research. The research will be reviewed and funded in a two-phase process. For this first phase, ORI is seeking small-scale, developmental research projects. ORI anticipates that Phase I awards will have a ceiling of up to $75,000 for a period of 12 months 

The Office of Research Integrity (ORI) seeks to support conferences to develop multi-disciplinary networks to build upon existing evidence-based research and stimulate innovative approaches to preventing research misconduct and promoting research integrity. ORI is especially interested in supporting conferences that lead to extramural grant applications on research on research integrity and peer-reviewed publications.

Dong Xiao, Ph.D. admitted that he had “intentionally fabricated data contained in a paper entitled ‘Guggulsterone inhibits prostate cancer growth via inactivation of Akt regulated by ATP citrate signaling."

ORI found that Dr. Bin Kang engaged in research misconduct by falsifying data that were included in the following two publications and two grant applications.